$ATRS ANTARES PHARMA, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ANTARES PHARMA, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ANTARES PHARMA, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ANTARES PHARMA, INC. for free.

CIK Number: 0001016169
IRS Number: 411350192
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: ATRS
Company Address: 100 PRINCETON SOUTH SUITE 300 EWING 08628
Former name: MEDI JECT CORP /MN/, date of change: 1996-06-05
Former name: ANTARES PHARMA INC /MN/, date of change: 2001-06-04
Former name: ANTARES PHARMA INC, date of change: 2002-05-20

Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.

Market Capitalization: $356.70M
Prev close: $2.20
Average Daily Volume: 923,232
Days Low: $2.16
Year Low: $0.67
Year High: $2.45

ANTARES PHARMA, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
APPLE ROBERT FPresident & CEO2,563,0335,638,673shares bought: 3,201,394 / shares sold: -2,206,860 BUYFeb 19 20213 months ago
GARRITY THOMAS JDirector274,406603,693shares bought: 434,193 / shares sold: -340,000 BUYMar 12 20212 months ago
GRAHAM PETER JEVP General Counsel, Secretary582,4901,281,478shares bought: 908,873 / shares sold: -357,496 STRONG BUYFeb 19 20213 months ago
GUETH ANTONDirector542,1251,192,675shares bought: 256,862 / shares sold: 0 STRONG BUYMay 06 20216 days ago
JACOB LEONARD SDirector268,363590,399shares bought: 728,132 / shares sold: -643,975 BUYFeb 19 20213 months ago
Powell Fred MExecutive Vice President & CFO726,8301,599,026shares bought: 805,379 / shares sold: -114,378 STRONG BUYFeb 19 20213 months ago
Richardson Peter CEVP, R&D Chief Medical Officer00Apr 28 202114 days ago

View all ANTARES PHARMA, INC. insiders.

ANTARES PHARMA, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 06 2021ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.6640,00066,4000
May 06 2021ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.6640,00066,400542,125502.1 K to 542.1 K (+7.97 %)
May 06 2021ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.6640,00066,4000
May 06 2021ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.6640,00066,400542,125502.1 K to 542.1 K (+7.97 %)
May 03 2021ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorOption ExerciseM1.6672,669120,6310
May 03 2021ATRSANTARES PHARMA, IN ...GUETH ANTONDirectorBuyM1.6672,669120,631502,125429.5 K to 502.1 K (+16.92 %)
Apr 28 2021ATRSANTARES PHARMA, IN ...Richardson Peter CEVP, R&D Chief Medi ...Option ExerciseA4.0159,179237,30859,179
Mar 12 2021ATRSANTARES PHARMA, IN ...GARRITY THOMAS JDirectorOption ExerciseM1.1250,00056,0000
Mar 12 2021ATRSANTARES PHARMA, IN ...GARRITY THOMAS JDirectorSellS4.2850,000214,000224,406274.4 K to 224.4 K (-18.22 %)
Mar 12 2021ATRSANTARES PHARMA, IN ...GARRITY THOMAS JDirectorBuyM1.1250,00056,000274,406224.4 K to 274.4 K (+22.28 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...Powell Fred MExecutive Vice Pres ...Payment of ExerciseF4.7335,829169,471691,001726.8 K to 691 K (-4.93 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...Powell Fred MExecutive Vice Pres ...GrantA0.0080,3650726,830646.5 K to 726.8 K (+12.43 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM0.88250,000220,0000
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM2.625,51914,4600
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS5.00241,9601,209,8002,204,7602.4 M to 2.2 M (-9.89 %)

View all ANTARES PHARMA, INC. insider transactions.